EUVIMEDEUVIMED entdecken
Crossref

Assessment of Early Detection by Multi-omics-Based Liquid Biopsy in Lung Cancer: A Prospective Study (ASCEND-LUNG)

Kezhong Cheng, Hongyi Kou, Kai Zhang, Yichen Jin, Peng Cui, Bo Yang, Yuxiao Liu, Chengyang Wang, Chengcheng Li, Yuzi Zhang, Guoqiang Wang, Xingyu Yang und 3 weitere

EMJ Oncology · 2022

DOI: 10.33590/emjoncol/10002372 ↗

Kurz gefasst

Fachartikel in der Zeitschrift EMJ Oncology, 2022. Verfasst von Kezhong Cheng und 14 weiteren Autor:innen. Die Arbeit nennt 4 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Cheng, K., Kou, H., Zhang, K., Jin, Y., Cui, P., Yang, B., Liu, Y., Wang, C., Li, C., Zhang, Y., Wang, G., Yang, X., Zhou, G., Cai, S., & Yang, F. (2022). Assessment of Early Detection by Multi-omics-Based Liquid Biopsy in Lung Cancer: A Prospective Study (ASCEND-LUNG). EMJ Oncology. https://doi.org/10.33590/emjoncol/10002372

Vancouver

Cheng K, Kou H, Zhang K, Jin Y, Cui P, Yang B, et al. Assessment of Early Detection by Multi-omics-Based Liquid Biopsy in Lung Cancer: A Prospective Study (ASCEND-LUNG). EMJ Oncology. 2022. doi:10.33590/emjoncol/10002372

BibTeX
@article{Cheng2022,
  author = {Cheng, Kezhong and Kou, Hongyi and Zhang, Kai and Jin, Yichen and Cui, Peng and Yang, Bo and Liu, Yuxiao and Wang, Chengyang and Li, Chengcheng and Zhang, Yuzi and Wang, Guoqiang and Yang, Xingyu and Zhou, Guangyu and Cai, Shangli and Yang, Fan},
  title = {Assessment of Early Detection by Multi-omics-Based Liquid Biopsy in Lung Cancer: A Prospective Study (ASCEND-LUNG)},
  journal = {EMJ Oncology},
  year = {2022},
  doi = {10.33590/emjoncol/10002372}
}
Kostenlos starten →